Cargando...
Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis
BACKGROUND: Recently, the addition of inhaled corticosteroid (ICS) to long-acting muscarinic antagonist (LAMA) and long-acting beta-agonist (LABA) combination therapy has been recommended for patients with COPD who have severe symptoms and a history of exacerbations because it reduces the exacerbati...
Gardado en:
| Publicado en: | Respir Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8218448/ https://ncbi.nlm.nih.gov/pubmed/34154582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-021-01777-x |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|